Interventional Cardiovascular Surgery

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

In conducting the ACTIVATION trial, Redwood and colleagues seek to complement the existing literature with high-level evidence on whether percutaneous coronary intervention (PCI) prior to TAVR is non-inferior to conservative (no PCI) management.

Through this registry-based analysis, the authors sought to assess short and long-term outcomes of revascularisation in a latecomer STEMI population presenting between 12 to 48 hours of symptom onset.

Structural valve deterioration remains the Achilles heel of both SAVR and TAVI. Since indications for TAVI have expanded to low-risk patients in 2019, this clinical scenario poses a significant conundrum for physicians and surgeons, as the number of patients undergoing aortic valve interventions continues to grow...

Coronary obstruction is a known procedural complication of aortic valve replacement. However, delayed presentation few months after surgical AVR is a relatively unusual phenomenon.  We describe a 75 year old woman with surgical AVR who presented with acute coronary syndrome and severe RV failure few months...

Ali Nazmi Calik and Pascal Meier review this trial comparing CEA with CAS for patients with asymptomatic carotid stenosis, which was presented by Alison Halliday (Oxford, United Kingdom of Great Britain & Northern Ireland) during a Hot Line session of the ESC Congress 2021.

Find out more about the case of a 72-year-old male, very active, previous smoker with hypertension, who underwent a stress echo for dyspnea on exertion...

Reviewers:

Michele Pighi et Flavio Luciano Ribichini

Paola Redaelli interviews first Fabien Praz then Francesco Maisano to get their feedback on transcatheter edge-to-edge repair for treatment of tricuspid regurgitation, as covered by the TRILUMINATE Trial. Compare the surgeon's perspective with the interventional cardiologist's perspective!

1. In most cases torrential TR remains at least severe after Triclip:...

Read more about the Nordic Aortic Valve Intervention (NOTION) trial to compare clinical outcomes and durability of bioprosthetic aortic valves 8 years after TAVI and SAVR.

In this session, discover how an effective calcium debridement procedure in stenotic aortic valves may restore the valve function, and why biometric indicators and engineering characteristics are so important for effective and safe delivery of endovascular care.